Diabetes treatment is constantly evolving, with new therapeutic options emerging to improve patient outcomes. Recent studies have focused on GLP-1 and GIP receptor agonists, a category of drugs that mimic the actions of naturally occurring hormones involved in bloodsugar regulation. These novel agents demonstrate substantial efficacy in improving b

The management of diabetes continues to evolve with the emergence of exciting new therapies. Among these, Reta, GLP-1 receptor agonists, Retatrutide, and Trizepatide are gaining significant attention. These medications offer promising approaches for controlling blood sugar levels and may improve the lives of individuals living with diabetes. Reta